Mirtazapine
Treatment for Amphetamine use disorders
Typical Dosage: 30-45mg daily
Effectiveness
35%
Safety Score
60%
Clinical Trials
8
Participants
700
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
60
DangerousModerateSafe
Treatment Details
Dosage Range
30-45mg daily
Time to Effect
2-4 weeks
Treatment Duration
12-24 weeks
Evidence Quality
LOWConfidence Score
50%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$200
Side Effect Mgmt:$75
Total Annual:$475
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORQALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$1,583
Cost per Remission
$4,750
Mirtazapine Outcomes
for Amphetamine use disorders
Efficacy Outcomes
Overall Effectiveness
+35%
Response Rate
+30%
Remission Rate
+10%
Common Side Effects
Sedation/Drowsiness
+30%
Increased appetite/Weight gain
+18%
Dry mouth
+15%
Dizziness
+10%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov